Yvon LEBRANCHU [clinicaltrials_resource:d5e5c2702eda7e548cae94da82145eec]
Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation [clinicaltrials:NCT01066689]Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation [clinicaltrials:NCT01350882]Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE) [clinicaltrials:NCT01744470]
overall official [clinicaltrials_vocabulary:overall-official]
Yvon LEBRANCHU [clinicaltrials_resource:d5e5c2702eda7e548cae94da82145eec]
Bio2RDF identifier
d5e5c2702eda7e548cae94da82145eec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d5e5c2702eda7e548cae94da82145eec
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
lebranchu@med.univ-tours.fr
last name [clinicaltrials_vocabulary:last-name]
Yvon LEBRANCHU
phone [clinicaltrials_vocabulary:phone]
02.47.47.82.29
role [clinicaltrials_vocabulary:role]
Principal Investigator
identifier
clinicaltrials_resource:d5e5c2702eda7e548cae94da82145eec
title
Yvon LEBRANCHU
@en
type
label
Yvon LEBRANCHU [clinicaltrials_resource:d5e5c2702eda7e548cae94da82145eec]
@en